Edition:
United Kingdom

BioCryst Pharmaceuticals Inc (BCRX.OQ)

BCRX.OQ on NASDAQ Stock Exchange Global Select Market

2.67USD
21 Aug 2019
Change (% chg)

-- (--)
Prev Close
$2.67
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
547,649
52-wk High
$9.94
52-wk Low
$2.54

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Robert Ingram

76 2017 Independent Chairman of the Board

Jon Stonehouse

58 2007 President, Chief Executive Officer, Director

Thomas Staab

50 2018 Senior Vice President, Chief Financial Officer, Treasurer and Principal Accounting Officer

Yarlagadda Babu

66 2013 Senior Vice President - Drug Discovery

William Sheridan

64 2008 Senior Vice President, Chief Medical Officer